Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001654954-18-011715
Filing Date
2018-10-30
Accepted
2018-10-30 16:30:30
Documents
2
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A vtgn10qa_sep302018.htm 10-Q/A 61859
2 LICENSE AGREEMENT ex10-3.htm EX-10.3 186940
  Complete submission text file 0001654954-18-011715.txt   249906
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

EIN.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q/A | Act: 34 | File No.: 001-37761 | Film No.: 181147307
SIC: 2834 Pharmaceutical Preparations